Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis
A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Sponsor: EyePoint Pharmaceuticals, Inc.
Listed as NCT02746991, this PHASE3 trial focuses on Intermediate Uveitis and Panuveitis and remains completed. Sponsored by EyePoint Pharmaceuticals, Inc., it has been updated 14 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 9 earlier versions
-
Oct 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jul 2020 — Aug 2020 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
May 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — May 2020 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EyePoint Pharmaceuticals, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ahmedabad, India , Chennai, India , Daryāganj, India , Guwahati, India , Hyderabad, India , Kanpur, India , Kolkata, India , Lucknow, India , Mumbai, India , Noida, India and 2 more locations